APA (7th ed.) Citation

GC, M., DH, S., JA, S., & RJ, D. (2026). Target trial emulation of biologic and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis-associated interstitial lung disease. Seminars in arthritis and rheumatism, 78, 152973. https://doi.org/10.1016/j.semarthrit.2026.152973

Chicago Style (17th ed.) Citation

GC, McDermott, Solomon DH, Sparks JA, and Desai RJ. "Target Trial Emulation of Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drugs for Rheumatoid Arthritis-associated Interstitial Lung Disease." Seminars in Arthritis and Rheumatism 78 (2026): 152973. https://doi.org/10.1016/j.semarthrit.2026.152973.

MLA (9th ed.) Citation

GC, McDermott, et al. "Target Trial Emulation of Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drugs for Rheumatoid Arthritis-associated Interstitial Lung Disease." Seminars in Arthritis and Rheumatism, vol. 78, 2026, p. 152973, https://doi.org/10.1016/j.semarthrit.2026.152973.